Folic acid supplementation reduces plasma homocysteine in postmenopausal women

References

• Albert CM, Cook NR, Gaziano JM, Zaharris E, Macfadyen J, Danielson E, et al. 2008. Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial. The Journal of the American Medical Association 299:2027–2036.
   PubMed Web of Science ®Google Scholar
• Bønaa KH, Njølstad I, Ueland PM, Schirmer H, Tverdal A, Steigen T, et al. 2006. NORVIT Trial Investigators. Homocysteine lowering and cardiovascular events after acute myocardial infarction. The New England Journal of Medicine 354:1578–1588.
   PubMed Web of Science ®Google Scholar
• Bozkurt N, Erdem M, Yilmaz E, Erdem A, Biri A, Kubatova A, et al. 2009. The relationship of homocyteine, B12 and folic acid with the bone mineral density of the femur and lumbar spine in Turkish postmenopausal women. Archives of Gynecology and Obstetrics 280:381–387.
   PubMed Web of Science ®Google Scholar
• Brouwer IA, van Dusseldorp M, Thomas CMG, Duran M, Hautvast JGAJ, Eskes TKAB, et al. 2000. Low-dose folic acid supplementation decreases plasma homocysteine concentrations: a randomized trial. Indian Heart Journal 52(7 Suppl):S53–S58.
   Google Scholar
• Ceperković Z. 2006. The role of increased levels of homocysteine in the development of cardiovascular diseases. Medicinski Pregled 59:143–147.
   PubMedGoogle Scholar
• Christodoulakos G, Panoulis C, Rizos D, Moustakarias T, Phocas I, Creatsas G. 2001. Homocysteine and folate levels in postmenopausal women. Maturitas 39:161–167.
   PubMed Web of Science ®Google Scholar
• de Bree A, van Mierlo LA, Draijer R. 2007. Folic acid improves vascular reactivity in humans: a meta-analysis of randomized controlled trials. The American Journal of Clinical Nutrition 86:610–617.
   PubMed Web of Science ®Google Scholar
• de Leo V, La Marca A, Morgante G, Musacchio MC, Luisi S, Petraglia F. 2004. Menopause, the cardiovascular risk factor homocysteine, and the effects of treatment. Treatments in Endocrinology 3:393–400.
   PubMedGoogle Scholar
• de Leo V, La Marca A, Morgante G, Ciani F, Zammarchi E, Setacci C. 2000. Low-dose folic acid supplementation reduces plasma levels of the cardiovascular risk factor homocysteine in postmenopausal women. Am J Obstet Gynecol 183:945–947.
   PubMed Web of Science ®Google Scholar
• Gambacciani M, Mannella P. 2007. Homocysteine, menopause and cardiovascular disease. Menopause International 13:23–26.
   PubMedGoogle Scholar
• Ghezzi F, Buttarelli M, Cromi A, Raio L, Cedars M, Bolis P. 2004. Plasma homocysteine levels after hormone therapy with and without folic acid supplementation: a randomized study. Fertil Steril 82:746–748.
   PubMed Web of Science ®Google Scholar
• Hak AE, Polderman KH, Westendorp IC, Jakobs C, Hofman A, Witteman JC, et al. 2000. Increased plasma homocysteine after menopause. Atherosclerosis 149:163–168.
   PubMed Web of Science ®Google Scholar
• Homocysteine Lowering Trialists’ Collaboration. 2005. Dose-dependent effects of folic acid on blood concentrations of homocysteine: a meta-analysis of the randomized trials. American Journal of Clinical Nutrition 82:806–812.
   PubMed Web of Science ®Google Scholar
• Homocysteine Studies Collaboration. 2002. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA: The Journal of the American Medical Association 288:2015–2022.
   PubMed Web of Science ®Google Scholar
• Lange H, Suryapranata H, de Luca G, Börner C, Dille J, Kallmayer K, et al. 2004. Folate therapy and in-stent re stenosis after coronary stenting. The New England Journal of Medicine 350:2673–2681.
   PubMed Web of Science ®Google Scholar
• Leboff MS, Narweker R, Lacroix A, Wu L, Jackson R, Lee J, et al. 2009. Homocysteine levels and risk of hip fracture in postmenopausal women. The Journal of Clinical Endocrinology and Metabolism 94:1207–1213.
   PubMed Web of Science ®Google Scholar
• Lonn E, Yusuf S, Arnold MJ, Sheridan P, Pogue J, Micks M, et al. 2006. Heart Outcomes Prevention Evaluation (HOPE) 2 Investigators. Homocysteine lowering with folic acid and B vitamins in vascular disease. The New England Journal of Medicine 354:1567–1577.
   PubMed Web of Science ®Google Scholar
• Marchesoni D, Driul L, Plaino L, Villani MT, Becagli L, Mozzanega B. 2003. Menopause rather than estrogen modifies plasma homocysteine levels. Int J Gynaecol Obstet 81:293–297.
   PubMed Web of Science ®Google Scholar
• Martí-Carvajal AJ, Solà I, Lathyris D. 2015. Homocysteine-lowering interventions for preventing cardiovascular events. Cochrane Database Syst Rev 1:CD006612. doi: 10.1002/14651858.CD006612.pub4.
   PubMed Web of Science ®Google Scholar
• Masse PG, Dosy J, Cole DE, Evrovski J, Mahuren JD, Coburn SP. 2005. Elevation of plasma homocysteine in natural menopause cannot be explained by a lack of vitamin coenzyme availability: relevance to the risk of cardiovascular disease. The Journal of Nutrition, Health and Aging 9:59–64.
   PubMed Web of Science ®Google Scholar
• Miller JW, Nadeau MR, Smith D, Selhub J. 1994. Vitamin B-6 deficiency VS folate deficiency: comparison of responses to methionine loading in rats. The American Journal of Clinical Nutrition 59:1033–1039.
   PubMed Web of Science ®Google Scholar
• Sato Y, Honda Y, Iwamoto J, Kanoko T, Satoh K. 2005. Effect of folate and mecobalamin on hip fractures in patients with stroke: a randomized controlled trial. JAMA: The Journal of the American Medical Association 293:1082–1088.
   PubMed Web of Science ®Google Scholar
• Schnyder G, Roffi M, Pin R, Flammer Y, Lange H, Eberli FR, et al. 2001. Decreased rate of coronary restenosis after lowering of plasma homocysteine levels. The New England Journal of Medicine 345:1593–1600.
   PubMed Web of Science ®Google Scholar
• Tighe P, Ward M, McNulty H, Finnegan O, Dunne A, Strain J, et al. 2011. A dose-finding trial of the effect of long-term folic acid intervention: implications for food fortification policy. The American Journal of Clinical Nutrition 93:11–18.
   PubMed Web of Science ®Google Scholar
• Toprak A, Erenus M, Ilhan AH, Haklar G, Fak AS, Oktay A. 2005. The effect of postmenopausal hormone therapy with or without folic acid supplementation on serum homocysteine level. Climacteric 8:279–286.
   PubMed Web of Science ®Google Scholar
• van Guelpen B, Hultdin J, Johansson I, Witthöft C, Weinehall L, Eliasson M, et al. 2009. Plasma folate and total homocysteine levels are associated with the risk of myocardial infarction, independently of each other and of renal function. Journal of internal medicine 266:182–195.
   PubMed Web of Science ®Google Scholar
• van Meurs JB, Dhonukshe-Rutten RA, Pluijm SM, van der Klift M, de Jonge R, Lindemans J, et al. 2004. Homocysteine levels and the risk of osteoporotic fracture. The New England Journal of Medicine 350:2033–2041.
   PubMed Web of Science ®Google Scholar
• van Meurs JB, Uitterlinden AG. 2005. Homocysteine and fracture prevention. JAMA: The Journal of the American Medical Association 293:1121–1122.
   PubMed Web of Science ®Google Scholar
• van Oort FV, Melse-Boonstra A, Brouwer IA, Clarke R, West CE, Katan MB, et al. 2003. Folic acid and reduction of plasma homocysteine concentrations in older adults: a dose-response study. The American Journal of Clinical Nutrition 77:1318–1323.
   PubMed Web of Science ®Google Scholar
• Wald DS, Law M, Morris JK. 2002. Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ (Clinical Research Ed) 325:1202.
   PubMed Web of Science ®Google Scholar
• Wald DS, Law M, Morris JK. 2004. The dose-response relation between serum homocysteine and cardiovascular disease: implications for treatment and screening. Eur J Cardiovasc Prev Rehabil 11:250–253.
   PubMedGoogle Scholar
• Wald DS, Wald NJ, Morris JK, Law M. 2006. Folic acid, homocysteine, and cardiovascular disease: judging causality in the face of inconclusive trial evidence. BMJ (Clinical Research Ed) 333:1114–1117.
   PubMed Web of Science ®Google Scholar
• Wouters MG, Moorrees MT, van der Mooren MJ, Bloom HJ, Boers GH, Schellekens LA, et al.1995. Plasma homocysteine and menopausal status. European Journal of Clinical Investigation 25:801–805.
   PubMed Web of Science ®Google Scholar